Keros Therapeutics, Inc.
Keros Therapeutics, Inc. (KROS) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 473 transactions totaling $288.0M, demonstrating a bearish sentiment with -$195.6M in net insider flow. The most recent transaction on Nov 21, 2025 involved a transaction of 130,494 shares valued at $2.3M.
KROS Insider Activity Summary
Who Is Buying KROS Stock?
No significant insider buying has been recorded for KROS in the recent period.
Who Is Selling KROS Stock?
No significant insider selling has been recorded for KROS in the recent period.
Is Keros Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for KROS is bearish with an Insider Alignment Score of 16/100 and a net flow of -$195.6M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
KROS Frequently Asked Questions
Understanding KROS Insider Activity
Insider trading at Keros Therapeutics, Inc. (KROS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading KROS stock, having executed 473 transactions in the past 90 days. The most active insider is Daniel Schneeberger (Executive), who has made 3 transactions totaling $95.7M.
Related Tools
Track Keros Therapeutics, Inc. Insider Activity
Get notified when executives and directors at KROS file new Form 4 transactions